Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue

[1]  G. Fleuren,et al.  Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach. , 2015, Fertility and sterility.

[2]  S. Silber,et al.  Fertility preservation for age-related fertility decline , 2014, The Lancet.

[3]  Jonhan Ho,et al.  Imaging of Mohs Micrographic Surgery Sections Using Full‐Field Optical Coherence Tomography: A Pilot Study , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  A. Vahrmeijer,et al.  Image-guided cancer surgery using near-infrared fluorescence , 2013, Nature Reviews Clinical Oncology.

[5]  F. V. van Leeuwen,et al.  Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. , 2013, Human reproduction update.

[6]  Cornelis J H van de Velde,et al.  Near‐infrared fluorescence‐guided resection of colorectal liver metastases , 2013, Cancer.

[7]  J. Gala,et al.  Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study , 2013, Journal of Assisted Reproduction and Genetics.

[8]  B. Giepmans,et al.  EpCAM: structure and function in health and disease. , 2013, Biochimica et biophysica acta.

[9]  Claus Yding Andersen,et al.  Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.

[10]  Jacques Donnez,et al.  Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. , 2013, Fertility and sterility.

[11]  T. Fleming,et al.  EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer , 2013, British Journal of Cancer.

[12]  D. Braat,et al.  Cryopreservation and Autotransplantation of Ovarian Tissue in Cancer Patients: Is It Safe? , 2013 .

[13]  Linlin Tang,et al.  The urokinase plasminogen activator system in breast cancer invasion and metastasis. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  J. Donnez,et al.  A review of 15 years of ovarian tissue bank activities , 2013, Journal of Assisted Reproduction and Genetics.

[15]  Zeev Blumenfeld,et al.  Chemotherapy and fertility. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[16]  K. Oktay,et al.  Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[17]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[18]  Merlijn Hutteman,et al.  The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery , 2011, Journal of surgical oncology.

[19]  M. Hutteman,et al.  Near-Infrared Fluorescence Imaging in Patients Undergoing Pancreaticoduodenectomy , 2011, European Surgical Research.

[20]  P. Quax,et al.  Clinical applications of the urokinase receptor (uPAR) for cancer patients. , 2011, Current pharmaceutical design.

[21]  Michael W. Anderson,et al.  Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. , 2011, Fertility and sterility.

[22]  Vasilis Ntziachristos,et al.  Enhancing Surgical Vision by Using Real-Time Imaging of αvβ3-Integrin Targeted Near-Infrared Fluorescent Agent , 2011, Annals of Surgical Oncology.

[23]  M. Montag,et al.  Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT , 2011, Archives of Gynecology and Obstetrics.

[24]  H. Gevensleben,et al.  Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers , 2011, Archives of Gynecology and Obstetrics.

[25]  A. Loft,et al.  Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. , 2011, Reproductive biomedicine online.

[26]  K. Friedrich,et al.  Prognostic relevance of tumour cell‐associated uPAR expression in invasive ductal breast carcinoma , 2010, Histopathology.

[27]  Alexander L. Vahrmeijer,et al.  Optical Image-guided Surgery—Where Do We Stand? , 2010, Molecular Imaging and Biology.

[28]  K. Oktay,et al.  Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. , 2010, Fertility and sterility.

[29]  S. Alahari,et al.  Important role of integrins in the cancer biology , 2010, Cancer and Metastasis Reviews.

[30]  J. Jeruss,et al.  Preservation of fertility in patients with cancer. , 2009, The New England journal of medicine.

[31]  A. Pellicer,et al.  Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. , 2009, Human reproduction.

[32]  Robert M Hoffman,et al.  Infrared multiphoton microscopy: subcellular-resolved deep tissue imaging. , 2009, Current opinion in biotechnology.

[33]  M. Werner,et al.  Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. , 2008, Anticancer research.

[34]  L. Norton,et al.  Expression of WT1, CA 125, and GCDFP-15 as Useful Markers in the Differential Diagnosis of Primary Ovarian Carcinomas Versus Metastatic Breast Cancer to the Ovary , 2005, The American journal of surgical pathology.

[35]  T. Rowlands,et al.  Cadherins and catenins in breast cancer. , 2005, Current opinion in cell biology.

[36]  W. McCluggage,et al.  Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features , 2005, Histopathology.

[37]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[38]  S. Eccles,et al.  Breast cancer metastasis: when, where, how? , 2005, The Lancet.

[39]  Michael D. Cahalan,et al.  Two-photon tissue imaging: seeing the immune system in a fresh light , 2002, Nature Reviews Immunology.

[40]  H. Marret,et al.  Incidence, diagnostic et pronostic des métastases ovariennes du cancer du sein , 2001 .

[41]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[42]  F. Kuhajda,et al.  The distribution of carcinoembryonic antigen in breast carcinoma diagnostic and prognostic implications , 1983, Cancer.

[43]  V. Subramaniam,et al.  The use of fluorescent dyes and probes in surgical oncology. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  M. Loscalzo,et al.  The psychosocial context of cancer-related infertility. , 2007, Cancer treatment and research.